Friday 18 May |
Paddy Power Betfair |
Independent News & Media |
AstraZeneca |
Computacenter |
Clarke (T) |
Petrofac |
John Menzies |
Derwent London |
Hikma Pharmaceuticals |
NEX Group (re acquisition by CME London) |
Monday 21 May |
BP |
Cloudcall Group |
Restore |
4D Pharma |
TBC Bank Group |
Secure Income REIT |
Tuesday 22 May |
Xaar |
Gulf Marine Services |
Menhaden Capital |
Forterra |
Stock Spirits Group |
Gocompare.com |
Arrow Global Group |
Fidelity Japanese Values |
Accesso Technology Group |
Wednesday 23 May |
Bovis Homes Group |
St James's Place |
Keller Group |
Gamma Communications |
Antofagasta |
Fundsmith Emerging Equities Trust |
Hilton Food Group |
Mercantile Investment Trust |
Polypipe Group |
Smart Metering Systems |
XLMedia |
Restaurant Group |
Central Asia Metals |
Allied Minds |
Xeros Technology Group |
Medica Group |
Bakkavor |
NAHL Group |
Boku |
Thursday 24 May |
Lloyds Banking Group |
Balfour Beatty |
Sound Energy |
Ibstock |
Sportech |
Alliance Pharma |
Henry Boot |
Enquest |
Hastings Group |
Headlam group |
Huntsworth |
Inchcape |
Intertek |
Spire Healthcare |
Tissue Regenix Group |
Learning Technologies Group |
Sabre Insurance Group |
eve Sleep |
Cambridge Cognition |
Arena Events |
Strix Group |
Yu Group |
Alliance Pharma expects no profit growth in 2024
(Sharecast News) - Consumer healthcare group Alliance Pharma has said that 2023 results will be in line with market expectations but said that profits are unlikely to grow this year due to increased investment in sales and marketing.
Read more